Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 541 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
26 Мб
Скачать
2 Duodenal Switch: Mechanisms ofFunctioning
19
In the rst years of the present century, the sleeve gastrectomy was reborn as a single standing weight loss operation [3]. Some reasons contributed, and probably the most important was its simplicity. But another important reason was that the observed weight loss was greater than expected; greater than that obtained with similar operations performed in the past, as it was the vertical banded gastroplasty or the Magenstrasse and Mill operation introduced by Johnston [4, 5]. The achieved weight loss with a sleeve gastrectomy was quite close to that obtained after a Roux­en- Y gastric bypass. The main difference between the sleeve gastrectomy and those old operations was the removal of the fundus instead of leaving it separated from the new gastric pouch. The fundus of the stomach is one of the places where the orexi­gen hormone ghrelin is secreted. It is true that ghrelin is also produced in the small intestine, the testicles, placenta, liver, or central nervous system, but when the fun­dus is removed, the levels of ghrelin are shown to drop drastically, and this seems to be related to early satiety and successful weight loss [6].
The decrease in ghrelin levels is a direct effect of the fundus resection. However, there are other hormonal effects not directly related to resection of its production area, as is the rise in glucagon like peptide-1 (GLP-1) secretion in patients submitted to sleeve gastrectomy. This has been demonstrated by Vives etal. [7] and appears to be related to the acceleration of gastric emptying after the sleeve resection combined with the poor processing of ailments in the operated stomach. On one hand, the gas­tric resection decreases the rst processing of food, as there is no antral mill where the particles are sieved into small ones that can be absorbed. In the other one, the rapid gastric emptying delivers this poorly processed food into the distal small bowel, stim­ulating the secretion of GLP-1 which, among different actions, accelerates satiation.
The gastric resection decreases nutrient absorption at least partially. This is sec­ondary to the limitation in the gastric phase of digestion. Secretion of pepsinogen, pepsin, hydrochloric acid, etc., is reduced, and this limits the initial gastric digestion of proteins and other nutrients, thus decreasing its absorption in the distal parts of the small bowel. The decrease in acid secretion also decreases the reduction of cat­ions into absorbable ions in the duodenum and proximal ileum, so iron and calcium absorption is expected to be substantially reduced.
2.3 Pyloric Preservation
The preservation of the pylorus is an extremely important part of the operation. To achieve a correct functioning of the valve we advocate a complete vascular and neural preservation, what means avoiding dissection at the lesser curve of the antrum and duodenum, leaving the right gastric artery untouched. The motor branches of the vagus nerve to the pylorus typically arise from the hepatic branch, which is a division of the anterior vagus nerve, and accompany the right gastric artery to reach the pylorus and innervate both this muscle and the proximal part of the duodenum [8]. Division of the right gastric artery will, invariably, also sever pyloric innervation.
20
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
A. Sánchez-Pernaute et al.
To improve mobilization of the duodenum with preservation of the lesser omen­tum, a full detachment of the posterior wall from the pancreatic surface must be achieved, while dissection should go beyond the gastroduodenal artery down to the common bile duct level. At this point is where the lesser omentum has to be incised to warrant full mobilization of the proximal duodenal stump without eliminating vascularization or innervation (Fig.2.2).
Empirically we speculate that if the pylorus regulates gastric emptying, and if gastric emptying regulates the incretinic response, the preservation of a normally functioning pylorus has to be important in the regulation of the metabolic syndrome, especially in diabetic patients [9]. The regulation of gastric emptying has the great advantage of the elimination of the dumping syndrome, which has been linked to bariatric operations since the very rst development of the gastric bypass. Dumping syndrome has been considered an adjuvant effect for weight loss, helping patients to abandon sweet-eating due to the unpleasant effect of the rapid gastric emptying. The post pyloric anastomosis eliminates this undesired complication improving the quality of life without affecting weight loss.
Another advantage, that is not empiricism, and has been thoroughly demon­strated, is the great benet in terms of long-term complications of a postpyloric anastomosis. The alkaline mucous secretion of the duodenum protects the anasto­mosis from ulceration and stricture, complications seen frequently in the gastro­jejunal anastomosis of the Roux-en-Y gastric bypass. Even in heavy smokers no such complications are observed affecting the proximal anastomosis of the duode­nal switch. The duodenal mucous secretion tamponade is not the only protection against anastomotic problems, as was demonstrated by the group of DeMeester in 1992, when they reported that a postpyloric anastomosis favored gastric emptying and maintained a normal gastric acid secretion, while on the other hand, a prepylo­ric one was related to a delay in gastric emptying and a greater—probably second­arily—gastric acid secretion with frequent anastomotic ulcer formation [10].
Fig. 2.2 Complete duodenal dissection with preservation of lesser curve vascularization and innervation. CBD common bile duct; RGA right gastric artery; GDA gastroduodenal artery
2 Duodenal Switch: Mechanisms ofFunctioning
21
2.4 Biliopancreatic Diversion
The term biliopancreatic diversion is referred to the separation of bile and pancre­atic juices from the area of the intestine where the aliments pass initially. The limb carrying these secretions will come together with the limb transporting the aliments distally in the small bowel, thus differing absorption to the distal intestine. Scopinaro introduced this concept of division of the small bowel to reduce the problems derived from the presence of a long blind limb, by anastomosis this one to the proxi­mal stomach. In this way three different limbs could be distinguished: the alimen­tary one, the biliopancreatic, and the common channel, this last one being where absorption will mainly take effect [1113]. This diversion was applied also to the Mason’s gastric bypass at the end of the 1970s by Ward O Griffen [14]. The differ­ence between both types of surgery laid on the long biliary limb and short common channel characterizing the biliopancreatic diversion.
Duodenal switch, as was Scopinaro’s operation, consists on a limited, usually 200–250cm, alimentary limb in which only a short amount of starch and proteins is absorbed, while water, electrolytes, and hydrosoluble vitamins absorption is main­tained. As the alimentary limb commences usually at the level of the proximal ileum, little if any hexose receptors are present at the mucosal surface, so absorption of hexoses is drastically reduced, what appears to be an early control mechanism of glycemia in diabetic patients.
Bile and pancreatic juices circulate through all the jejunum, losing part of their power to contribute in the absorption of proteins and fat, and come together with the ingested nutrients at 60–100cm from the ileocecal valve, where the common chan­nel starts. The length of the common channel warrants the maintenance of the entero-hepatic cycle, and, on the other hand, limits caloric absorption to not more than 1500 Kcal per day, independently of the amount of the intake [15].
The duodenal switch is possibly the most powerful metabolic operation, along with the Scopinaro procedure, as it gathers most of the mechanisms implied in the remission of diabetes: the bypass of the duodenum and pancreatic regions (foregut hypothesis); the emptying of the rst duodenal portion directly into the ileum, what causes early satiety and cooperates with gastric restriction, but also avoids contact of glucose with sodium glucose transport protein (SGLT) receptors; the stimulation of Takeda receptors in the intestinal L cells, what increases GLP-1 secretion; and the selective fat malabsorption, which secondary depletes liver fat deposits and also intra-myocyte fat, both related to insulin resistance and diabetes.
GLP-1 is probably the most amazing hormone related to obesity and obesity surgery. Its study has helped to develop powerful drugs currently used to treat obe­sity and diabetes or as adjuvant therapy to bariatric surgery. GLP-1 secretion is directly related to the amount of calories ingested, mainly carbohydrates. It is
22
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
A. Sánchez-Pernaute et al.
degraded by dipeptidyl peptidase-4 (DPP4). It enhances glucose-dependent insulin release and inhibits gastric emptying. It probably also has a direct effect on appetite­regulating centers in the central nervous system, as it also has an effect during star­vation. A rise in postprandial levels of GLP-1 is detected in patients submitted to duodenal switch, as well as in patients submitted to other types of malabsorptive operations [16]. Other intestinal peptides related to weight loss and metabolic improvement after duodenal switch and other bariatric surgeries are oxyntomodu­lin, which acts as GLP-1 inhibiting gastric emptying and reducing food intake, pep­tide YY (3–36), also liberated by the L cells in the ileum, but not so potent as GLP-1, and neurotensin, which is directly related to lipid absorption and insulin sensitivity and increases higher after biliopancreatic diversions than after the stan­dard Roux-en-Y gastric bypass [17].
Malabsorption-based operations do not enjoy a good press, in some respects deservedly; wrongly selected patients and non-compliant patients can have a highly impaired quality of life, mainly because of diarrhea and malnutrition. In a large series of experienced groups, these represent less than 5% of the cases, and those are because patients are thoroughly selected and followed, and supplementation is maintained from the early postoperative period [18]. Nutritional recommendations for patients undergoing duodenal switch include at least a total daily protein intake between 60 and 120g of pure protein, 1–1.5g/kg of ideal weight; fat should never exceed 30–35% of total caloric amount, as 20g daily is enough to warrant the absorption of essential fatty acids and an adequate function of the gallbladder. Vitamin D, calcium, and iron are the usually recommended supplementation, and sometimes also vitamins A and E.
2.5 Conclusion
Duodenal switch includes virtually all mechanisms involved in weight loss and metabolic improvement after a bariatric operation. Intake restriction, changes in bile acids and peptide secretion, and a controlled limitation to absorption are all present in this highly effective operation. Selection of patients and an adequate per­formance of the surgical technique to decrease postoperative and long-term compli­cations should warrant a satisfactory and maintained long-term effect.
2 Duodenal Switch: Mechanisms ofFunctioning
23
References
1. Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15:408–16.
2. DeMeester TR, Fuchs KH, Ball CS, Albertucci M, Smyrck TC, Marcus JN.Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reux. Ann Surg. 1987;206:414–26.
3. Regan JP, Inabnet WB, Gagner M, Pomp A.Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.
4. Mason EE.Vertical banded gastroplasty for obesity. Arch Surg. 1982;117:701–6.
5. Johnston D, Dachtler J, Sue-Ling HM, King RF, Martin IG.The Magenstrasse and Mill opera­tion for morbid obesity. Obes Surg. 2003;13:10–6.
6. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G.Sleeve gastrectomy and gastric banding: effects on plasma Ghrelin levels. Obes Surg. 2005;15:1024–9.
7. Vives M, Molina A, Danús M, Rebenaque E, Blanco S, París M, Sánchez A, Sabench F, Del Castillo D.Analysis of gastric physiology after laparoscopic sleeve gastrectomy (LSG) with or without antral preservation in relation to metabolic response: a randomised study. Obes Surg. 2017;27:2836–44.
8. Skandalakis LJ, Gray SW, Skandalakis JE.The history and surgical anatomy of the vagus nerve. Surg Gynecol Obstet. 1986;162:75–85.
9. Roslin M, Damani T, Oren J, Andrews R, Yatco E, Shah P.Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia. Surg Endosc. 2011;25:1926–32.
10. Welch NT, Yasui A, Kim CB, Barlow AP, Hinder RA, DeMeester TR, Polishuk PV, Adrian TE.Effect of duodenal switch procedure on gastric acid production, intragastric pH, gastric emptying, and gastrointestinal hormones. Am J Surg. 1992;163:37–45.
11. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V.Bilio-pancreatic bypass for obe­sity: I.An experimental study in dogs. Br J Surg. 1979;66:613–7.
12. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V.Bilio-pancreatic bypass for obe­sity: II.Initial experience in man. Br J Surg. 1979;66:618–20.
13. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V.Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr. 1980;33:506–14.
14. Griffen WO Jr, Young VL, Stevenson CC.A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977;186:500–9.
15. Scopinaro N.Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg. 2006;16:683–9.
16. Hellström PM.Satiety signals and obesity. Curr Op Gastroenterol. 2013;29:2222–7.
17. Von Loeffelholz C, Castagneto Gissey L, Schumann T, Henke C, Kurzbac A, Struck J, Bergmann A, Hanefeld M, Schatz U, Bornstein SR, Casella G, Mingrone G, Birkenfeld AL.The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery. Int J Obes. 2018;42:2057–61.
18. Biertho L, Lebel S, Marceau S, Hould FS, Julien F, Biron S.Biliopancreatic diversion with duo­denal switch: surgical technique and perioperative care. Surg Clin North Am. 2016;96:815–26.
Chapter 3
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Duodenal Switch andIts Derivatives
Yen-YiJuo andRanjanSudan
3.1 Introduction
Despite the relative popularity of Roux-en-Y gastric bypass and sleeve gastrectomy [1], DS results in both the greatest magnitude of excess weight loss and the most reliable resolution of comorbidities, especially type II diabetes [2].
However, duodenal switch is currently not widely practiced. As of 2019, DS accounted for only 0.9% of all bariatric surgeries performed in the USA [3]. This is likely a result of factors such as the performance of DS requires both advanced lapa­roscopic technical skills, expert judgement in patient selection, and reliable follow­ up for nutritional parameters. Also, the procedure is generally perceived as having higher peri-operative complications as well as increased risks of long-term nutri­tional deciencies [4].
Nevertheless, DS is recently enjoying a resurgence of clinical interest, partly due to the spread of advanced laparoscopic skills, and, perhaps most importantly, the rising prevalence of super morbid obesity (BMI>50kg/m2) [5] and weight recidi­vism after sleeve gastrectomy [6]. Due to these reasons, we believe that DS should continue to be in the arsenal for high-volume bariatric surgeons.
In this chapter, we seek to provide an in-depth overview of the pre-operative, procedural, and post-operative clinical management of patients undergoing DS sur­gery or one of its derivative procedures.
Y.-Y. Juo · R. Sudan (*) Department of Surgery, Duke University School of Medicine, Durham, NC, USA e-mail: yenyi.juo@duke.edu; ranjan.sudan@duke.edu
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 A. Teixeira et al. (eds.), Duodenal Switch and Its Derivatives in Bariatric and Metabolic Surgery, https://doi.org/10.1007/978-3-031-25828-2_3
25
26
Y.-Y. Juo and R. Sudan
3.2 History
Biliopancreatic diversion was initially described by Scopinaro etal. as a combina­tion of two procedures: a partial gastrectomy and distal intestinal bypass. The par­tial gastrectomy involves a creation of a 250 mL gastric pouch and the distal intestinal bypass creates a 50cm common channel and a 250 cm alimentary limb [7]. This procedure was subsequently modied due to the relatively high rate of dumping and marginal ulcers. The modernized version of this procedure, also known as biliopancreatic diversion with duodenal switch (BPD-DS), involves the creation of a sleeve gastrectomy, thereby preserving the pylorus, and the creation of a duodenal-ileal anastomosis [8]. This would allow preservation of the pylorus and reduce the parietal cell mass, leading to decreased rates of dumping and ulcer formation.
3.3 Derivative Procedures ofDuodenal Switch
While early reports of BPD-DS were of open surgery, Ren etal. described the earli­est laparoscopic BPD-DS [9] and our group reported the rst report of robotic­assisted BPD-DS in 2000 [10]. With the evolution and advancement of robotic technology, this technique has evolved from a hybrid procedure to a totally robotic technique. By docking the robot one time, there is less dependence on a bedside assistant and improved efciency within the operation. This book chapter describes and illustrates the robotic-assisted BPD-DS technique utilized by our group since November 2011.
Besides the advance in minimally invasive surgical approaches, the recent evolu­tion of BPD-DS has developed several derivative procedures. The most popular derivative procedure is the adoption of sleeve gastrectomy as a standalone bariatric procedure, the details of which will be described in a separate chapter in this book. One other variation of BPD-DS that has gained increasing attention is the SADI-S (single-anastomosis duodeno-ileal bypass with sleeve gastrectomy), also known simply as “SADI,” “loop DS,” or “SIPS” (stomach intestinal pylorus sparing). SADI was rst described by Sanchez-Pernaute etal. in 2007 [11]. The main differences between SADI and a formal BPD-DS are the omission of the ileo-ileal anastomosis, thus converting the Roux-en-Y conguration of the duodeno-ileostomy into a loop conguration and the alimentary limb lengths.
Whether it is appropriate to abandon the Roux construction is one of the most contentious debate subjects among bariatric surgeons. Many surgeons are con­cerned about the potential for bile reux from a loop duodeno-ileostomy. In fact,
3 Duodenal Switch andIts Derivatives
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
27
duodenal switch was initially described as a treatment for bile reux gastritis [12]. On the other hand, some argue that SADI anatomy actually reduces bile reux gas­tritis in comparison with normal anatomy, because bile will rst be diluted and partially absorbed as it travels through several meters of the small intestine before reaching the area of the anastomosis. Furthermore, bile must resist the forward peri­stalsis of the small intestine and reux through the anastomosis and the pylorus before reaching the gastric mucosa. Currently there is no strong evidence support­ing the claim that bile reux from SADI anatomy could cause gastric dysplasia and esophageal cancer [13].
On the other hand, SADI is attractive to modern surgeons due to the creation of a longer common limb, lessening the fears of some regarding the malabsorptive risks of formal BPD-DS.In fact, many see it as a “milder” version of BPD-DS.It has been endorsed by american society of metabolic and bariatric surgery (ASMBS) as an appropriate metabolic bariatric procedure, with caution advised regarding concerns about intestinal adaptation, nutritional issues, optimal limb lengths, and long-term outcomes [14]. Short-term weight loss efcacy appears comparable between SADI and BPD-DS, but recent studies are demonstrating signicantly inferior total body weight loss and excess weight loss for SADI than formal BPD-DS.On the other hand, there is also a lower incidence of protein deciency and bowel obstruction after SADI than formal BPD-DS [15].
3.4 Pre-operative Consideration
3.4.1 Indications forSurgery
No consensus indications for BPD-DS exists outside that of those for bariatric sur­gery based on the 1992 National Institutes of Health Consensus Development Conference Statement, namely, BMI greater than or equal to 40kg/m2 or a BMI of 35kg/m2 or greater with signicant medical comorbidities [16]. However, BPD-DS is often reserved for patients with BMI over 50kg/m2 [17] or poorly controlled metabolic diseases [18].
As with any bariatric procedure, a multidisciplinary evaluation is necessarily pre-operatively. This includes a medical, nutritional, and psychological evaluation. The medical evaluation includes a comprehensive laboratory evaluation, pre­operative electrocardiogram, and chest X-Ray. Additional preoperative tests are per­formed on an individualized basis and beyond the scope of this chapter but the readers are referred to a detailed publication on the subject [19]. Pre-operative weight loss is frequently recommended with either the patient’s primary care physi­cian or with the bariatric surgeon.
28
Y.-Y. Juo and R. Sudan
3.4.2 Contraindications
Some contraindications to BPD-DS are similar to bariatric surgery in general, such as inability to tolerate general anesthesia, non-correctable coagulopathy, preexisting malabsorptive disorder such as inammatory bowel disease or celiac disease, or active malignancy.
Relative contraindications to BPD-DS include severe gastroesophageal reux, which may be worsened by the sleeve gastrectomy anatomy, according to some [20]. Furthermore, due to the relatively higher incidence of malnutrition after sur­gery, a higher standard for psychosocial ability to comply with postoperative instructions is necessary. BPD-DS candidates need to demonstrate adequate social support, full understanding of nutritional consequences of the procedure, ability to maintain close follow-up, and absolutely no active alcohol or substance abuse. Furthermore, the patient needs to demonstrate willingness and nancial ability to obtain the necessary nutritional supplementations on a long-term basis after surgery.
3.5 Procedural Details
3.5.1 Patient Positioning andPort Placement
The patient is placed in a supine with position, with the arms spread out at right angles and the legs together. Secure strapping of the patient and a footboard is man­datory, as a steep reverse-Trendelenburg position will be necessary during portions of the procedure involving the upper abdomen. Extremities are padded meticulously to prevent skin breakdown or neuropathy from pressure. The operating surgeon stands to the patient’s right side for the majority of the case while the assistant stands to the patient’s left. The scrub nurse stands at the foot of the bed next to the assistant.
Peritoneal access is obtained based on surgeon preference. In our practice, we routinely create pneumoperitoneum with a Veress needle (Medtronic, Norwalk, CT) at the Palmer’s point before entering the peritoneal cavity under direct visualization with an 8mm optical trocar in the supraumbilical midline, approximately 15cm below the xiphoid process. Port positions are described for the Xi version of the Intuitive Surgical robot. A 12mm accessory laparoscopic port for the bedside assis­tant is placed in the left and right subcostal area. Additional 8mm robotic ports are placed in the left anterior axillary line (arm 1), right midclavicular line (arm 3), and the right anterior axillary line (arm 4). The camera is in the supraumbilical position and docked to arm 2 (see Fig.3.1).
3 Duodenal Switch andIts Derivatives
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 3.1 Port position illustration. Arm 1 at the right anterior axillary line, arm 2 at the right midclavicular line, and arm 4 at the left mid clavicular. Arm 3, the camera port, is in the midline. Liver retractor (LR) is at the subxiphoid area slightly left of midline. An assistant port for laparoscopic instrument access is placed in the left subcostal area between arm 3 and 4
29
3.5.2 Laparoscopic Portion
The patient is rst placed in Trendelenburg position to allow identication of the terminal ileum. With laparoscopic instruments, the ileum is measured in a retro­grade manner from the ileocecal valve, until marking stitches could be placed at 100 and 250cm from the ileocecal valve. We then anchor the small bowel at the 250cm mark to the anterior abdominal wall, in the right upper quadrant, in proximity to the duodenum. This allows it to be easily identied when fashioning the duodeno-ileal anastomosis later (see Fig.3.2).
We then place the patients in a steep reverse-Trendelenburg position for place­ment of a Nathanson retractor before docking the robot from the patient’s right ank.
3.5.3 Cholecystectomy
Due to the anticipated dramatic weight loss and the wasting of bile, patients often have cholelithiasis or choledocholithiasis after BPD-DS [21], therefore, we have adopted it as standard practice to perform concomitant cholecystectomy dur­ing BPD-DS.